Pharmacologic treatment for postpartum depression: a systematic review

scientific article published on September 2010

Pharmacologic treatment for postpartum depression: a systematic review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1592/PHCO.30.9.928
P698PubMed publication ID20795848

P2093author name stringPatrick R Finley
Ellen Haller
Winnie Yeung
Cheryl K Hirata
Rosalyn C Ng
P2860cites workOmega-3 fatty acids: evidence basis for treatment and future research in psychiatryQ28281056
Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot studyQ30907762
The effectiveness of exercise in the management of post-natal depression: systematic review and meta-analysisQ33397987
Effects of gonadal steroids in women with a history of postpartum depressionQ33903674
Onset and persistence of postpartum depression in an inner-city maternal health clinic system.Q34100217
The omega-3 story: nutritional prevention of preterm birth and other adverse pregnancy outcomesQ34239131
The safety of newer antidepressants in pregnancy and breastfeedingQ34390866
Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetineQ34775057
Gender differences in depression and response to antidepressant treatmentQ35561518
Mood disturbance in the early puerperium: a reviewQ35582933
Prevalence of suicidality during pregnancy and the postpartumQ36121838
Prevention and treatment of postnatal depressionQ36817068
Analysis of positive Edinburgh depression scale referrals to a consultation liaison psychiatry service in a two-year periodQ36834324
Antidepressant use in the postpartum period: practical considerationsQ36922809
A reproductive subtype of depression: conceptualizing models and moving toward etiologyQ37089316
Management of postnatal depressionQ37238659
Transdermal estradiol for postpartum depression: a promising treatment optionQ37435819
Essential fatty acids in pregnancy and early human developmentQ40940104
Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled studyQ41106513
Women's views of antidepressants in the treatment of postnatal depression.Q42648086
Prevalence, onset and comorbidity of postpartum anxiety and depressive disordersQ43691637
Fluvoxamine for postpartum depressionQ43752251
Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysisQ43901012
Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive womenQ43941619
Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processingQ44442042
Role functioning and symptom remission in women with postpartum depression after antidepressant treatmentQ44699793
Omega-3 polyunsaturated fatty acids for postpartum depressionQ44787434
Alterations in platelet serotonin transporter binding in women with postpartum onset major depressionQ45068225
Bupropion SR for the treatment of postpartum depression: a pilot studyQ46427315
Nefazodone for the treatment of postpartum depressionQ46469694
Sex differences in antidepressant response in recent antidepressant clinical trialsQ46596828
Efficacy of the kampo medicine xiong-gui-tiao-xue-yin (kyuki-chouketsu-in), a traditional herbal medicine, in the treatment of maternity blues syndrome in the postpartum periodQ47279486
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant actionQ48153911
Dysregulation of the hypothalamic-pituitary-adrenal axis in postpartum depressionQ48336624
Health-related quality of life in postpartum depressed womenQ48529177
Psychopathology and marital satisfaction: the importance of evaluating both partners.Q50989782
Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period.Q51113577
Patient choice of treatment for postpartum depression: a pilot study.Q51913324
Postpartum depression treatment rates for at-risk women.Q51919290
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression.Q51922714
Effects of Maternal Depression on Cognitive Development of Children Over the First 7 Years of LifeQ56637142
Obsessive-compulsive symptoms in pregnancy and the puerperium:Q56804378
A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormonesQ58053410
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectpostpartum depressionQ935129
pharmacologyQ128406
systematic reviewQ1504425
P304page(s)928-941
P577publication date2010-09-01
P1433published inPharmacotherapyQ7180800
P1476titlePharmacologic treatment for postpartum depression: a systematic review
P478volume30

Reverse relations

cites work (P2860)
Q37362209A pilot study evaluating genetic and environmental factors for postpartum depression
Q37688604Are antidepressants effective in the treatment of postpartum depression? A systematic review
Q28071504Chinese Herbal Medicine for Postpartum Depression: A Systematic Review of Randomized Controlled Trials
Q46780905Detection and treatment rates for perinatal depression in a state Medicaid population
Q48358069Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling
Q36455917Efficacy of light therapy for perinatal depression: a review
Q35092485Enhanced responsiveness to selective serotonin reuptake inhibitors during lactation
Q43447962Group treatment for depression in mothers of young children compared to standard individual therapy
Q34143957How generalized CNS arousal strengthens sexual arousal (and vice versa).
Q48514039Korean Medication Algorithm for Depressive Disorders 2017: Third Revision.
Q27024923Perinatal depression: an update and overview
Q36639113Postpartum depression: psychoneuroimmunological underpinnings and treatment
Q34426059Trajectories of depressive symptoms over 2 years postpartum among overweight or obese women

Search more.